Wednesday, September 24, 2008

California bankruptcy court

Article source Link




The stock dipped 21 cents, or 7.1 percent, to $2.76 in afternoon trading. Shares have traded between $2.10 and $5.29 over the last 52 weeks.
On Tuesday, the company said the U.S. District Court for the District of Delaware granted Amgen (nasdaq: AMGN - news - people )'s motion for summary judgment a series of noninfringement claims related to related to Enbrel. The drug is approved as a treatment for arthritis and psoriasis, among other conditions, and is made in partnership with Wyeth.
The court found that the administration of Enbrel falls outside of Ariad's asserted claims




Beach umbrella anchor

Remington bronze statues

Horse morgan

Ri bankruptcy court

Quarter horse congress

Garden buddha statue

Horse racing forum

Arkansas court records

Us horse racing

Wholesale patio umbrellas

Labels: